Fennec Pharmaceuticals Inc. (FENC): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

Older than the company's other figures. The latest EBITDA is for the year ended 2013-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report Depreciation & Amortization, which EBITDA is computed from, under the concepts TickerFacts maps.

-$1.93M
Year ended 2013-12-31
2011-12-31: -$3.44M2012-12-31: -$3.62M2013-12-31: -$1.93M-$1.93M
2011-12-31 EBITDA (USD) 2013-12-31
Period endedEBITDAChange YoYSource filing
2013-12-31-$1.93Mn/m2015-03-31, From 2013-01-01
2012-12-31-$3.62Mn/m2014-03-31, From 2012-01-01
2011-12-31-$3.44Mn/a2013-04-01, From 2011-01-01